NPS PHARMACEUTICALS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
NPS PHARMACEUTICALS INC had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $7.16 per share as of 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2015-02-18
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $7.16.
- 2014-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $6.84.
- 2014-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $6.47.
- 2014-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $6.37.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2014-12-31 | $7.16 10-K · filed 2015-02-18 |
| 2014-09-30 | $6.84 10-Q · filed 2014-11-10 |
| 2014-06-30 | $6.47 10-Q · filed 2014-08-06 |
| 2014-03-31 | $6.37 10-Q · filed 2014-05-08 |
| 2013-12-31 | $6.69 10-K · filed 2014-02-18 |
| 2013-09-30 | $6.40 10-Q · filed 2013-11-06 |
| 2013-06-30 | $6.54 10-Q · filed 2013-08-08 |
| 2013-03-31 | $6.67 10-Q · filed 2013-05-09 |
| 2012-12-31 | $6.76 10-K · filed 2013-02-21 |